Author:
Lachmann N,Czarnecki K,Brennig S,Phaltane R,Heise M,Heinz N,Kempf H,Dilloo D,Kaever V,Schambach A,Heuser M,Moritz T
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference15 articles.
1. Moritz T, Williams DA . Marrow protection - transduction of hematopoietic cells with drug resistance genes. Cytotherapy 2001; 3: 67–84.
2. Adair JE, Johnston SK, Mrugala MM, Beard BC, Guyman LA, Baldock AL et al. Gene therapy enhances chemotherapy tolerance and efficacy in glioblastoma patients. J Clin Invest 2014; 124: 4082–4092.
3. Adair JE, Beard BC, Trobridge GD, Neff T, Rockhill JK, Silbergeld DL et al. Extended survival of glioblastoma patients after chemoprotective HSC gene therapy. Sci Transl Med 2012; 4: 133ra157.
4. Klanova M, Lorkova L, Vit O, Maswabi B, Molinsky J, Pospisilova J et al. Downregulation of deoxycytidine kinase in cytarabine-resistant mantle cell lymphoma cells confers cross-resistance to nucleoside analogs gemcitabine, fludarabine and cladribine, but not to other classes of anti-lymphoma agents. Mol Cancer 2014; 13: 159.
5. Lachmann N, Brennig S, Phaltane R, Flasshove M, Dilloo D, Moritz T . Myeloprotection by cytidine deaminase gene transfer in antileukemic therapy. Neoplasia 2013; 15: 239–248.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献